Clinical trial

Ultrasound-Guided Mid-Transverse Process to Pleura Block for Analgesia in Pediatric Thoracotomy: A Randomized Controlled Study

Name
MTP block
Description
The aim of this study is to assess the effectiveness of analgesia of US guided MTP block in pediatrics undergoing thoracotomy.
Trial arms
Trial start
2024-01-01
Estimated PCD
2024-08-01
Trial end
2024-09-01
Status
Not yet recruiting
Treatment
Bupivacaine
Before skin incision, under complete aseptic precautions and sterilization, the patient will be placed in a lateral position. The spinous process of the fourth thoracic vertebra will be identified and marked. The ultrasound guided MTP block will be done by high frequency linear transducer will be placed in position just lateral to the spinous processes of thoracic vertebra target of the paravertebral space. A 50 mm 22-gauge echogenic needle will be inserted in an in plane technique from a caudal to a cephalad direction and will be advanced. When the needle tip reaches the midpoint between the transverse process and the pleura, 1 ml normal saline will be injected. Once the needle tip has been confirmed and after careful aspiration to demonstrate the absence of air or blood, 0.5mL/kg 0.25% bupivacaine will be injected.
Arms:
general anesthesia and ultrasound guided MTP block
Other names:
Mid transverse process to pleural block
Size
50
Primary endpoint
The total dose of morphine consumption in the first postoperative 24 hours.
24 hours postoperative
Eligibility criteria
Inclusion Criteria: * The study will include 50 pediatric patients of both sexes aged from 5 to 15 years old with American Society of Anesthesiologists physical status I\& II undergoing elective open thoracotomy. Exclusion Criteria: * Refusal of parents. * Repeated thoracotomy. * Emergency surgery. * Mechanically ventilated patients. * Bleeding disorders. * Allergy to study drugs. * Infection at the site of the needle puncture.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 50, 'type': 'ESTIMATED'}}
Updated at
2024-01-11

1 organization

1 product

3 indications

Organization
Tanta University
Indication
Analgesic